Quetiapine 200mg tablets are a potent medication designed for the management of several psychiatric conditions. As an atypical antipsychotic, it offers a favorable balance between efficacy and tolerability, making it a preferred choice for clinicians and patients alike.
Product Specifications:
- Active Ingredient: Quetiapine fumarate, equivalent to 200mg of quetiapine.
- Classification: Atypical antipsychotic.
- Formulation: Immediate-release oral tablets.
- Mechanism of Action: Dopamine and serotonin (5-HT) receptors antagonist.
- Bioavailability: Well-absorbed with peak plasma concentrations occurring within 1.5 hours.
- Metabolism: Hepatic, primarily via cytochrome P450 3A4.
- Half-life: Approximately 7 hours.
- Excretion: Renal and fecal.
Common Applications:
- Schizophrenia: Effective in both acute and maintenance treatment of schizophrenia.
- Bipolar Disorder: Used for the acute treatment of manic episodes and as a maintenance therapy to prevent recurrence.
- Major Depressive Disorder: Employed as an adjunct therapy for treatment-resistant depression.
User Groups:
- Adults with diagnosed psychiatric conditions such as schizophrenia, bipolar disorder, and major depressive disorder.
- Not recommended for pediatric patients or elderly patients with dementia-related psychosis due to increased risk of adverse effects.
Supplier Overview - Sandoz:
Sandoz, a division of the multinational pharmaceutical company Novartis, is a global leader in the production of generic pharmaceuticals and biosimilars. With a commitment to increasing access to high-quality medicines, Sandoz is an authority in the field of atypical antipsychotics, including Quetiapine 200mg tablets. Their rigorous quality control, extensive research and development, and dedication to patient well-being position Sandoz as a trusted supplier in the pharmaceutical landscape. Sandoz's expertise in generic medication manufacturing ensures that Quetiapine 200mg tablets are produced to the highest standards, providing a reliable and effective option for the management of psychiatric disorders.